Valeant international. inc
- Contact:J. Michael Pearson
- Tel: 674-635-986524
- Mail: valeantinc@gmail.com
Main product: Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops and markets prescription and nonprescription pharmaceutical products
All products
-
CharSol C 10 (87139-45-5)
-
1,2,3-Propanetriol, (12040-65-2 )
-
serratamolide (5285-25-6 )
-
Pyrazine,3,5-diethyl (18138-05-1 )
-
CK-37 (144190-25-0 )
-
Ammonium Dibutyl Dit (53378-51-1 )
-
Carbamothioic acid,N (141-98-0 )
-
1-Propanol,2,2'-oxyb (108-61-2 )
-
1,2-Ethanediol,1,2-d (629-15-2 )
-
1-pentyl-3-(2-methyl (864445-39-6 )
-
Norglaucine (21848-62-4 )
-
(4-diazoniophenyl)(t (15489-88-0 )
-
Benzeneacetonitrile, (16662-46-7 )
-
3,5-Cyclohexadiene-1 (583-63-1 )
-
Morphinan-6-one,4,5- (131575-03-6 )
-
1-(1,3-benzodioxol-5 (6974-61-4 )
-
7-Chloro-1,3-dihydro (4547-02-8 )
-
3,3',3''-[(1H,3H,5H) (67873-91-0 )
-
Butorphanol tartrate (58786-99-5 )
-
Doxifluridine (3094-09-5 )